Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB26FYM51
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EXPAREL 266 mg/20 mL vials. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is effective through November 28, 2025, and represents a single transaction under DMS Pharmaceutical Group's broader relationship with the federal pharmaceutical supply chain.
This delivery order is authorized under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The prime contractor, which holds no identified subcontractors, is positioned as a critical pharmaceutical supplier serving military healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous delivery orders and its comprehensive product portfolio spanning branded and generic pharmaceuticals, biologics, vaccines, and specialty surgical products demonstrate its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FYM51?
SPE2DB26FYM51 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FYM51 worth?
The government has obligated $25,106 on SPE2DB26FYM51.
Is contract SPE2DB26FYM51 an order under another contract?
Yes. SPE2DB26FYM51 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM51 competed?
The extent of competition for SPE2DB26FYM51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award